
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PARP-10 CRISPR/Cas9 KO Plasmid (m) | sc-437160 | 20 µg | $397.00 |
Parp10 encodes PARP-10, a mono-ADP-ribosyltransferase that regulates protein function through ADP-ribosylation, influencing protein stability, subcellular localization, and signaling outputs. PARP-10 has been linked to control of DNA damage responses, replication stress tolerance, and chromatin-associated processes, integrating with ubiquitin-dependent protein regulation and other post-translational modification networks. In mouse systems, PARP-10 activity is commonly investigated in the context of genome maintenance, cell-cycle progression, and stress-adaptive signaling that shapes cellular homeostasis. Dysregulation of ADP-ribosylation pathways is broadly associated with aberrant proliferation and inflammatory signaling, making Parp10 a useful node for mechanistic studies of pathway crosstalk in disease-relevant models.
PARP-10 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Parp10 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Parp10 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Parp10 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish PARP-10 protein expression.
This CRISPR knockout system enables efficient generation of Parp10-deficient cell models for investigation of PARP-10 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.